Nutraceutical firm sells D-glucarate business

- Last updated on GMT

Related tags: Marketing

Nutraceutix, a US producer of ingredients and technologies for the
nutraceutical industry, is to sell its D-glucarate business to
another licensor of the product, BioChemix.

Nutraceutix, a US producer of ingredients and technologies for the nutraceutical industry, is to sell its D-glucarate business to another licensor of the product, BioChemix. Under the terms of the agreement Nutraceutix gained $480,570 (525.442 euros) from the sale and will discontinue all sales, marketing, and distribution activities related to D-Glucarate. In the fiscal year 2000, Nutraceutix had gross revenues of $774,000 (846,271 euros) from the sale of bulk D-glucarate raw material. BioChemix will continue marketing D-glucarate through its joint venture partner, Glucona BV. David Howard, President & CEO of Nutraceutix, Inc. commented," This agreement allows Nutraceutix​ to focus on our core business strategy going forward, which has changed considerably with the acquisition of new intellectual property in both our probiotic business and our novel and patented CDT™ technologies. We are now able to concentrate on business opportunities aligned with our core competencies and intellectual property position."

Related topics: Suppliers

Follow us

Products

View more

Webinars